Powered by

Stem Cell Medicine Licenses Exosome Technology for Treating Autism From Ramot at Tel Aviv University

Jan 02, 2019 - PR Newswire

PR Newswire

Stem Cell Medicine Ltd. (SCM), a biotechnology company developing new therapies for neurological indications, including mesenchymal stem cells and anti-BMP molecules for the treatment of Multiple Sclerosis, and gene therapy for the treatment of neuropathic pain, has licensed an innovative exosomes based technology for the treatment of neurodegenerative and neuropsychiatric indications, specifically, autism spectrum disorder (ASD). The treatment is based on vesicles, exosomes, d...